PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

LVAD patients benefit from heart injection with millions of powerful cells

New study results presented at AHA Scientific Sessions 2013 show a single dose of stem cell therapy during surgery may improve new LVAD patients' heart function

2013-11-19
(Press-News.org) Contact information: Lauren Woods
lauren.woods@mountsinai.org
646-634-0869
The Mount Sinai Hospital / Mount Sinai School of Medicine
LVAD patients benefit from heart injection with millions of powerful cells New study results presented at AHA Scientific Sessions 2013 show a single dose of stem cell therapy during surgery may improve new LVAD patients' heart function

A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network (CTSN), led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left ventricular assist device (LVAD) heart pump may also benefit from a single dose of millions of powerful cells injected directly into their heart during surgery.

The CTSN, whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, conducted the clinical trial in collaboration with the Cardiovascular Cell Therapy Research Network.

Allogeneic mesenchymal precursor cells (MPCs), are a subpopulation of adult mesenchymal stem cells, which when harvested from a healthy donor's bone marrow can be selected and expanded in the laboratory into hundreds of millions of MPCs.

At the American Heart Association Scientific Sessions 2013 on November 18, Icahn School of Medicine at Mount Sinai's research team presented the new findings for this novel, first-ever randomized, double-blinded multicenter trial assessing the safety and efficacy of injecting a single dose of 25 million MPCs directly into the heart muscle of advanced heart failure patients receiving an LVAD for either bridge-to-transplant or as a destination therapy.

Study results show one dose of the MPC therapy may contribute to improved heart muscle recovery in advanced heart failure patients who received an LVAD. In their study, researchers reported that 50 percent of patients who received MPCs were able to tolerate temporarily turning down their LVAD heart pump, compared to 20 percent of the placebo patients. In addition, no patients developed serious side effects that may be associated with the stem cell injections.

"These clinical trial results provide important data about the safety and potential efficacy of a single MPC injection at the time of LVAD implantation," says the study's lead author Deborah D. Ascheim, MD, Associate Professor of Health Evidence and Policy and Cardiology at Icahn School of Medicine at Mount Sinai, who serves as Co-Director of the Data and Clinical Coordinating Center based at Mount Sinai for the NIH-sponsored Cardiothoracic Surgical Trials Network (CTSN) who conducted the clinical trial study.

"These mesenchymal precursor cells have shown their potential to safely facilitate early heart tissue repair in advanced heart failure. We look forward to investigating the benefits of this cell therapy further," says Dr. Ascheim.

The thirty LVAD patients enrolled in the clinical trial were randomized 2:1 at 11 clinical sites to evaluate the single dose injection of MPCs. Patients were assigned to either receive an injection of 25 million MPCs, or a placebo. All patients were followed until a heart transplant was received or until one-year.

The CTSN has eight core clinical centers across the country. It's Data and Clinical Coordinating Center, based at Icahn School of Medicine at Mount Sinai, leads each of its clinical trial's design, methodologies, ethical research concerns, study data, analysis, and data reporting.



INFORMATION:



The company that makes this experimental MPC therapy is Mesoblast, Inc.

This study was presented at the AHA Scientific Sessions as a Clinical Science Special Report (Abstract 19673): Intramyocardial Injection of Allogeneic Mesenchymal Precursor Cells in Left Ventricular Assist Device Patients.

About the Mount Sinai Health System

The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care.

The System includes approximately 6,600 primary and specialty care physicians, 12-minority-owned free-standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.

For more information, visit http://www.mountsinai.org.

Find Mount Sinai on:

Facebook: http://www.facebook.com/mountsinainyc
Twitter @mountsinainyc
YouTube: http://www.youtube.com/mountsinainy



ELSE PRESS RELEASES FROM THIS DATE:

Study may impact guidelines for mitral valve surgery for severe ischemic mitral regurgitation

2013-11-19
Study may impact guidelines for mitral valve surgery for severe ischemic mitral regurgitation New findings showing mitral valve replacement may be more effective than mitral valve repair reported at AHA Scientific Sessions ...

Long-lasting gene therapy benefits advanced heart failure patients

2013-11-19
Long-lasting gene therapy benefits advanced heart failure patients Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai report promising long-term follow-up results for its single dose AAV1/SERCA2a gene ...

People with highly superior powers of recall also vulnerable to false memories

2013-11-19
People with highly superior powers of recall also vulnerable to false memories UCI study reveals that common distortions seem to be shared by all Irvine, Calif., Nov. 19, 2013 — People who can accurately remember details of their daily lives going back decades ...

Advanced CT imaging proves as accurate as invasive tests to assess heart blockages, study shows

2013-11-19
Advanced CT imaging proves as accurate as invasive tests to assess heart blockages, study shows Study data from 16 hospitals in 8 countries are published in the European Heart Journal An ultrafast, 320-detector computed tomography (CT) scanner that shows both ...

Monkeys can point to objects they do not report seeing

2013-11-19
Monkeys can point to objects they do not report seeing The localization and detection capabilities of monkeys dissociate much like those of humans do Are monkeys, like humans, able to ascertain where objects are located without much more than ...

Brain imaging reveals dynamic changes caused by pain medicines

2013-11-19
Brain imaging reveals dynamic changes caused by pain medicines Study suggests role for brain imaging to create personalized treatment of chronic pain ANN ARBOR, Mich. – A study in the December issue of Anesthesiology suggests a role for brain ...

Many pediatricians uncomfortable providing care to kids with genetic conditions

2013-11-19
Many pediatricians uncomfortable providing care to kids with genetic conditions New study finds general physicians order few genetic tests, don't always discuss risks and benefits; take limited family histories Ann Arbor, Mich. — Many primary care pediatricians ...

Natural compound mitigates effects of methamphetamine abuse, University of Missouri researchers find

2013-11-19
Natural compound mitigates effects of methamphetamine abuse, University of Missouri researchers find COLUMBIA, Mo. – Studies have shown that resveratrol, a natural compound found in colored vegetables, fruits and especially grapes, may minimize the ...

New models predict where E. coli strains will thrive

2013-11-19
New models predict where E. coli strains will thrive Bioengineers at the University of California, San Diego have used the genomic sequences of 55 E. coli strains to reconstruct the metabolic repertoire for each strain. Surprisingly, these reconstructions ...

UEA research reveals how farmers could mitigate nitrous oxide emissions

2013-11-19
UEA research reveals how farmers could mitigate nitrous oxide emissions Farmers may be able to help reduce emissions of the greenhouse gas nitrous oxide (N2O) by incorporating copper into crop fertilisation processes – according to new research from the University ...

LAST 30 PRESS RELEASES:

Older teens who start vaping post-high school risk rapid progress to frequent use

Corpse flowers are threatened by spotty recordkeeping

Riding the AI wave toward rapid, precise ocean simulations

Are lifetimes of big appliances really shrinking?

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

[Press-News.org] LVAD patients benefit from heart injection with millions of powerful cells
New study results presented at AHA Scientific Sessions 2013 show a single dose of stem cell therapy during surgery may improve new LVAD patients' heart function